Hepatitis C and steatosis.
Publication
, Journal Article
Dev, A; Patel, K; McHutchison, JG
Published in: Clin Liver Dis
November 2004
Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly impacts therapeutic response. Research efforts should continue to focus on defining the complex viral and host interactions involved in the pathogenesis of HCV-related steatosis so that future therapeutic strategies may be accurately and appropriately targeted.
Duke Scholars
Published In
Clin Liver Dis
DOI
ISSN
1089-3261
Publication Date
November 2004
Volume
8
Issue
4
Start / End Page
881 / ix
Location
United States
Related Subject Headings
- Risk Factors
- Humans
- Hepatitis C, Chronic
- Hepacivirus
- Genotype
- Gastroenterology & Hepatology
- Fatty Liver
- Disease Progression
- Antiviral Agents
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dev, A., Patel, K., & McHutchison, J. G. (2004). Hepatitis C and steatosis. Clin Liver Dis, 8(4), 881–ix. https://doi.org/10.1016/j.cld.2004.06.007
Dev, Anouk, Keyur Patel, and John G. McHutchison. “Hepatitis C and steatosis.” Clin Liver Dis 8, no. 4 (November 2004): 881–ix. https://doi.org/10.1016/j.cld.2004.06.007.
Dev A, Patel K, McHutchison JG. Hepatitis C and steatosis. Clin Liver Dis. 2004 Nov;8(4):881–ix.
Dev, Anouk, et al. “Hepatitis C and steatosis.” Clin Liver Dis, vol. 8, no. 4, Nov. 2004, pp. 881–ix. Pubmed, doi:10.1016/j.cld.2004.06.007.
Dev A, Patel K, McHutchison JG. Hepatitis C and steatosis. Clin Liver Dis. 2004 Nov;8(4):881–ix.
Published In
Clin Liver Dis
DOI
ISSN
1089-3261
Publication Date
November 2004
Volume
8
Issue
4
Start / End Page
881 / ix
Location
United States
Related Subject Headings
- Risk Factors
- Humans
- Hepatitis C, Chronic
- Hepacivirus
- Genotype
- Gastroenterology & Hepatology
- Fatty Liver
- Disease Progression
- Antiviral Agents
- 3202 Clinical sciences